SHOCKING: 5 - What They Never Told You

Novo Nordisk Just Announced Wegovy Subscriptions. Does That Make NVO Stock a Buy?

Wegovy subscriptions may create interest, but there is a major threat looming for Novo Nordisk.

Barchart · Apr 2

Foundayo vs Zepbound: How Eli Lilly’s new weight loss pill compares to its injectable

IN FULL

The Independent UK · Apr 2

Diabetes advocates cross their fingers as a bipartisan bill revives efforts to lower insulin costs

A bipartisan group of senators is aiming to relieve high insulin costs for more Americans

The Independent UK · Apr 2

The FDA just approved triple the previous maximum dose of Wegovy

People taking ‘Wegovy HD’ lost an average of 21 percent of their body weight after 72 weeks

The Independent UK · Mar 25

Stopping GLP-1s can reverse cardiovascular benefits within six months, study finds

Discontinuing the drugs leaves a ‘lasting scar,’ researchers at WashU Medicine say

The Independent UK · Mar 19

What is ‘eye stroke’ and why has it been linked to weight loss injections?

The phrase “eye stroke” has recently appeared in news reports about a very rare side-effect of weight-loss injections. It’s not a formal medical diagnosis, but a shorthand used to describe a condition in which reduced blood flow damages the optic nerve and causes sudden vision loss.

The Conversation · Mar 18

Ozempic Controversy Deepens as FDA Accuses Novo Nordisk of Failing to Report Patient Deaths, One Linked To Suicide

Novo Nordisk faces FDA scrutiny for failing to report Ozempic-linked deaths, highlighting systemic issues in safety reporting. Learn about the implications for patient safety and ongoing legal challenges.

International Business Times UK · Mar 16

Label unhealthy foods, weight drug boss tells Australia

Workplace health checks, clearer labels on unhealthy foods and better education would help Australia reduce high rates of obesity, a drug company chief says.

AAP · Mar 16

Illegal weight loss jabs being sold in London pubs and fish and chip shops, report claims

It is alleged beauticians and personal trainers are exploiting soaring interest in weight loss jabs

Evening Standard · Mar 14

Feds warn Ozempic and Wegovy maker over failure to report side-effects from weight-loss drugs

Officials wrote that Novo Nordisk had failed to failed to report ‘serious and unexpected’ adverse drug experiences

The Independent UK · Mar 12